Lantern Pharma CEO to Showcase AI-Driven Glioblastoma Treatment at 2026 Summit
February 10, 2026 — Lantern Pharma CEO presents AI-driven glioblastoma treatment STAR-001 at 2026 summit. Learn how RADR® AI platform accelerates oncology drug development for aggressive brain cancers.